StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
BioLineRx Ltd.
Tel Aviv Stock Exchange:BLRX.TA
Sector
Industries
Location
Market Cap
USD 18.19 M
Share Price
USD 0.01
Avg Daily Volume
10,089,224
Change (1 day)
4.39%
Change (1 year)
-81.08%
Change (YTD)
-56.00%
BioLineRx Ltd. EBITDA for the year ending December 31, 2024: USD 3.92 M
BioLineRx Ltd. EBITDA is USD 3.92 M for the year ending December 31, 2024, a -106.86% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
BioLineRx Ltd. EBITDA for the year ending December 31, 2023 was USD -57.09 M, a 100.28% change year over year.
-
BioLineRx Ltd. EBITDA for the year ending December 31, 2022 was USD -28.50 M, a 18.40% change year over year.
-
BioLineRx Ltd. EBITDA for the year ending December 31, 2021 was USD -24.07 M, a 7.77% change year over year.
-
BioLineRx Ltd. EBITDA for the year ending December 31, 2020 was USD -22.34 M, a -16.92% change year over year.
Competitors
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
CSL Limited
USD 158.31
CSL.AX
-1.36
-0.85%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%
MERCK Kommanditgesellschaft auf Aktien
USD 131.84
MRK.DE
-2.06
-1.54%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.93
600276.SS
-0.09
-1.14%
Takeda Pharmaceutical Company Limited
USD 29.69
4502.T
+0.05
0.17%
Key Data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Competitors
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
CSL Limited
USD 158.31
CSL.AX
-1.36
-0.85%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%
MERCK Kommanditgesellschaft auf Aktien
USD 131.84
MRK.DE
-2.06
-1.54%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.93
600276.SS
-0.09
-1.14%
Takeda Pharmaceutical Company Limited
USD 29.69
4502.T
+0.05
0.17%